Molecular targets of isothiocyanates in cancer: Recent advances

被引:149
|
作者
Gupta, Parul [1 ,2 ]
Kim, Bonglee [3 ]
Kim, Sung-Hoon [3 ]
Srivastava, Sanjay K. [1 ,2 ,3 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Amarillo, TX 79106 USA
[3] Kyung Hee Univ, Coll Korean Med, Dept Pathol, Canc Prevent Mat Dev Res Ctr, Seoul, South Korea
关键词
BITC; Cancer; Isothiocyanate; PEITC; Sulforaphane; HUMAN PROSTATE-CANCER; CELL-CYCLE ARREST; NF-KAPPA-B; BETA-PHENYLETHYL ISOTHIOCYANATE; EPITHELIAL-MESENCHYMAL TRANSITION; ACETYLCYSTEINE CONJUGATE SUPPRESS; DIETARY PHENETHYL ISOTHIOCYANATE; HISTONE DEACETYLASE INHIBITORS; G(2)/M PHASE ARREST; NITRIC-OXIDE NO;
D O I
10.1002/mnfr.201300684
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Cancer is a multistep process resulting in uncontrolled cell division. It results from aberrant signaling pathways that lead to uninhibited cell division and growth. Various recent epidemiological studies have indicated that consumption of cruciferous vegetables, such as garden cress, broccoli, etc., reduces the risk of cancer. Isothiocyanates (ITCs) have been identified as major active constituents of cruciferous vegetables. ITCs occur in plants as glucosinolate and can readily be derived by hydrolysis. Numerous mechanistic studies have demonstrated the anticancer effects of ITCs in various cancer types. ITCs suppress tumor growth by generating reactive oxygen species or by inducing cycle arrest leading to apoptosis. Based on the exciting outcomes of preclinical studies, few ITCs have advanced to the clinical phase. Available data from preclinical as well as available clinical studies suggest ITCs to be one of the promising anticancer agents available from natural sources. This is an up-to-date exhaustive review on the preventive and therapeutic effects of ITCs in cancer.
引用
收藏
页码:1685 / 1707
页数:23
相关论文
共 50 条
  • [31] Isothiocyanates in the chemoprevention of bladder cancer
    Tang, L
    Zhang, YS
    CURRENT DRUG METABOLISM, 2004, 5 (02) : 193 - 201
  • [32] Targets and molecular mechanisms of triptolide in cancer therapy
    Meng, Cuicui
    Zhu, Hongcheng
    Song, Hongmei
    Wang, Zhongming
    Huang, Guanhong
    Li, Defan
    Ma, Zhaoming
    Ma, Jianhua
    Qin, Qin
    Sun, Xinchen
    Ma, Jianxin
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (05) : 622 - 626
  • [33] Recent advancement in the synthesis of isothiocyanates
    Maeda, Bumpei
    Murakami, Kei
    CHEMICAL COMMUNICATIONS, 2024, 60 (21) : 2839 - 2864
  • [34] Novel Anticancer Agents and Targets: Recent Advances and Future Perspectives
    Barot, Kuldipsinh P.
    Nikolova, Stoyanka
    Ivanov, Illiyan
    Ghate, Manjunath D.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (09) : 1239 - 1255
  • [35] Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets
    Fontana, Fabrizio
    Raimondi, Michela
    Marzagalli, Monica
    Di Domizio, Alessandro
    Limonta, Patrizia
    CELLS, 2020, 9 (02)
  • [36] The Role of Isothiocyanates as Cancer Chemo-Preventive, Chemo-Therapeutic and Anti-Melanoma Agents
    Mitsiogianni, Melina
    Koutsidis, Georgios
    Mavroudis, Nikos
    Trafalis, Dimitrios T.
    Botaitis, Sotiris
    Franco, Rodrigo
    Zoumpourlis, Vasilis
    Amery, Tom
    Galanis, Alex
    Pappa, Aglaia
    Panayiotidis, Mihalis I.
    ANTIOXIDANTS, 2019, 8 (04)
  • [37] Recent Advances on Cytotoxic Sesquiterpene Lactones
    Quintana, Jose
    Estevez, Francisco
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (36) : 4355 - 4361
  • [38] Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin
    Tian Wei
    Chen Si-yu
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2013, 19 (04) : 315 - 320
  • [39] Plant Coumestans: Recent Advances and Future Perspectives in Cancer Therapy
    Nehybova, Tereza
    Smarda, Jan
    Benes, Petr
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (10) : 1351 - 1362
  • [40] Recent Advances on the Role of ATGL in Cancer
    Zhang, Renshuai
    Meng, Jingsen
    Yang, Shanbo
    Liu, Wenjing
    Shi, Lingyu
    Zeng, Jun
    Chang, Jing
    Liang, Bing
    Liu, Ning
    Xing, Dongming
    FRONTIERS IN ONCOLOGY, 2022, 12